KURA - Kura Oncology, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - KURA (1422143)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
4 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2018-12-17
KURAEcor1 Capital Fund Qualified, L.P.10%S - Sale$13.20-26,5204,408,097-1%-$350,064
M
2018-12-18
KURAEcor1 Capital Fund Qualified, L.P.10%P - Purchase$13.57+213,8884,408,097+5%+$2,901,833
M
2018-12-11
KURAEcor1 Capital Fund Qualified, L.P.10%P - Purchase$13.90+40,5384,220,729+1%+$563,362
M
2018-12-03
KURAEcor1 Capital Fund Qualified, L.P.10%P - Purchase$13.50+119,9064,180,919+3%+$1,618,255
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top